Healthcare is changing in front of us.
Data, intelligence, and clinical insight are finally converging in ways many of us have been working toward for decades. For the first time, we can begin to understand patient journeys as they actually unfold—not in fragments, but in full context.
We can see patterns that were previously invisible.
We can learn faster, act sooner, and ultimately help more people.
That possibility feels personal. And it feels urgent.
I became an oncologist because I wanted to help patients one at a time, but over the course of my career, I’ve come to believe the bigger opportunity is helping patients we’ll never meet—by making the system itself smarter.
Truveta is where that vision becomes real.
For me, this is the most meaningful leadership opportunity of my career. It’s a chance to help shape what this team has built into an enduring company—one that can become the definitive intelligence platform at the intersection of science, health systems, and AI.
What the Truveta team has already accomplished is extraordinary. They’ve brought together health systems that rarely work side by side, built a platform that respects the complexity, sensitivity, and responsibility that come with clinical data, and created tools that allow researchers, clinicians, and innovators to understand real-world care with a level of clarity that simply didn’t exist before.
That foundation was earned through years of conviction, hard work, and a shared belief in Saving Lives with Data.
I’m honored to join a team that has built so much—and still feels like it’s just getting started.
After years across academic medicine, health systems, and life sciences—at Moffitt Cancer Center, Myriad Genetics, and most recently Regeneron—I’ve seen how transformative real-world evidence can be when it’s done right.
As President and Chief Scientific Officer, I’ll lead Truveta’s scientific strategy and ecosystem partnerships. That means working across science, product, and execution to deepen collaboration with health systems, researchers, and life sciences partners—and translating data into evidence and real-world impact, measured in outcomes that matter.
The impact of this work is especially tangible in oncology.
Imagine being able to surface early signals hidden across imaging, labs, pathology, symptoms, and outcomes. Imagine clearly seeing where diagnosis is delayed, where access to next-line therapies is uneven, and how treatments perform in real time across diverse communities.
These insights can guide care, inform research, and move us closer to clinical outcomes that are both better and more equitable.
With the right data and intelligence, we can strengthen safety monitoring, identify treatment response patterns earlier, reduce delays in care that cost lives, and give researchers the ability to explore important questions in days instead of months.
This is how a healthcare system learns continuously.
I’m joining Truveta because I believe this is the moment to build that future—one where insight arrives faster, care becomes more precise, and patients live longer, healthier lives because we used the information already within our reach to help them.
This is where we can build something lasting—the definitive intelligence platform for healthcare, one that scales globally and becomes essential infrastructure for how medicine discovers, decides, and delivers. This is how we change the trajectory of healthcare.
My wife Luciene and I talk often about what it means to build something that matters—and how you recognize that kind of opportunity when it arrives. This wasn’t a decision I made lightly. This is that moment.
To my colleagues, collaborators, and partners across the industry: thank you for the work we continue to do together. I look forward to what we build next.
The work is personal. The moment is urgent. Let’s get started.